FDA 483 - ByHeart Inc dba Blendhouse Allerton - February 11, 2025

The provided text elucidates the fundamental purpose and regulatory framework behind an FDA Form 483. This document is issued by the Food and Drug Administration (FDA) to report observed objectionable conditions or practices identified during an inspection of an establishment. The issuance of a Form 483 serves two key functions: it is a requirement under Section 704(b) of the Federal Food, Drug, and Cosmetic (FD&C) Act, and it also assists inspected firms in understanding and complying with FDA acts and regulations. The regulatory framework, specifically FD&C Act Section 704(b), mandates that upon completion of an inspection, the FDA officer must provide a written report to the owner or agent in charge, detailing any conditions that suggest a product (food, drug, device, or cosmetic) may be adulterated—meaning it is filthy, putrid, decomposed, or has been handled under unsanitary conditions leading to contamination or potential health injury. A copy of this report is subsequently sent to the Secretary. While this content explains the legal basis and general scope of an FDA 483, the provided text does not contain specific details such as a company name, actual inspection dates, main violations or issues observed, or any required corrective actions that would typically be present in a complete FDA Form 483 document.